5 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 32026-10-07NCT07195695
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseasesinterstitial lung disease, lung disorder, respiratory system disorderActive, not recruitingPhase 32026-10-02NCT06806592
A Study to Test Whether Nerandomilast Helps People With Systemic SclerosisSkin and Connective Tissue Diseases, connective tissue disorder, skin disorder, systemic sclerosisRecruitingPhase 32026-09-30NCT07497087
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 32026-09-29NCT07472517
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumSkin Ulcer, Skin and Connective Tissue Diseases, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular diseaseRecruitingPhase 32026-09-02NCT06624670